Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up

Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up

Objective: Immunadapt is a study evaluating the impact of combination antiretroviral treatment (cART) simplification on immune activation. We previously showed that switching to dual therapies could be associated six months later with macrophage activation. Followup continued up to 24 months after t...

Full description

Bibliographic Details
Main Authors: Matteo Vassallo, Jacques Durant, Roxane Fabre, Laurene Lotte, Audrey Sindt, Annick Puchois, Anne De Monte, Renaud Cezar, Pierre Corbeau, Christian Pradier
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Viruses
Subjects:
HIV
successful treatment
simplification strategies
inflammation
macrophage activation
Online Access:https://www.mdpi.com/1999-4915/14/5/927

Internet

https://www.mdpi.com/1999-4915/14/5/927

Similar Items